These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 23512182)

  • 21. Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy.
    Glascock JJ; Shababi M; Wetz MJ; Krogman MM; Lorson CL
    Biochem Biophys Res Commun; 2012 Jan; 417(1):376-81. PubMed ID: 22172949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic assessment of a cell model of spinal muscular atrophy.
    Wu CY; Whye D; Glazewski L; Choe L; Kerr D; Lee KH; Mason RW; Wang W
    BMC Neurosci; 2011 Mar; 12():25. PubMed ID: 21385431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
    Liu H; Shafey D; Moores JN; Kothary R
    J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy.
    Lomonte P; Baklouti F; Binda O
    Biochemistry; 2020 Apr; 59(14):1391-1397. PubMed ID: 32227847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
    Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
    Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset.
    Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP
    Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
    Gavrilina TO; McGovern VL; Workman E; Crawford TO; Gogliotti RG; DiDonato CJ; Monani UR; Morris GE; Burghes AH
    Hum Mol Genet; 2008 Apr; 17(8):1063-75. PubMed ID: 18178576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy.
    Butchbach ME; Singh J; Thorsteinsdóttir M; Saieva L; Slominski E; Thurmond J; Andrésson T; Zhang J; Edwards JD; Simard LR; Pellizzoni L; Jarecki J; Burghes AH; Gurney ME
    Hum Mol Genet; 2010 Feb; 19(3):454-67. PubMed ID: 19897588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
    Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
    Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse.
    McGovern VL; Massoni-Laporte A; Wang X; Le TT; Le HT; Beattie CE; Rich MM; Burghes AH
    PLoS One; 2015; 10(7):e0132364. PubMed ID: 26134627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
    Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
    Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a tamoxifen inducible SMN mouse for temporal SMN replacement.
    Bebee TW; Gladman JT; Chandler DS
    Genesis; 2011 Dec; 49(12):927-34. PubMed ID: 21538807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective.
    Blatnik AJ; McGovern VL; Burghes AHM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The water extract of Liuwei dihuang possesses multi-protective properties on neurons and muscle tissue against deficiency of survival motor neuron protein.
    Tseng YT; Jong YJ; Liang WF; Chang FR; Lo YC
    Phytomedicine; 2017 Oct; 34():97-105. PubMed ID: 28899515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice.
    Torres-Benito L; Schneider S; Rombo R; Ling KK; Grysko V; Upadhyay A; Kononenko NL; Rigo F; Bennett CF; Wirth B
    Am J Hum Genet; 2019 Jul; 105(1):221-230. PubMed ID: 31230718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.
    Williams JH; Schray RC; Patterson CA; Ayitey SO; Tallent MK; Lutz GJ
    J Neurosci; 2009 Jun; 29(24):7633-8. PubMed ID: 19535574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.
    Jangi M; Fleet C; Cullen P; Gupta SV; Mekhoubad S; Chiao E; Allaire N; Bennett CF; Rigo F; Krainer AR; Hurt JA; Carulli JP; Staropoli JF
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2347-E2356. PubMed ID: 28270613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.
    Seo J; Singh NN; Ottesen EW; Sivanesan S; Shishimorova M; Singh RN
    PLoS One; 2016; 11(4):e0154390. PubMed ID: 27111068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal requirement for high SMN expression in SMA mice.
    Le TT; McGovern VL; Alwine IE; Wang X; Massoni-Laporte A; Rich MM; Burghes AH
    Hum Mol Genet; 2011 Sep; 20(18):3578-91. PubMed ID: 21672919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.